Your Health, We Care
Enasidenib is indicated for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation as detected by an FDAapproved test.
FDA,2023.12
Encidipine is a new type of drug that has attracted a lot of attention in the me···【more】
Release date：2024-12-26Recommended：113
